Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014102HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30014108HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047831HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047832HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30047833HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS30017454HIVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20032025HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20022411HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TVIS20020749HPVENSG00000105397.16protein_codingTYK2YesNo7297P29597
TCGA Plot Options
Drug Information
GeneTYK2
DrugBank IDDB11763
Drug NameMomelotinib
Target IDBE0004146
UniProt IDP29597
Regulation Typeinhibitor
PubMed IDs31450973
CitationsXu L, Feng J, Gao G, Tang H: Momelotinib for the treatment of myelofibrosis. Expert Opin Pharmacother. 2019 Nov;20(16):1943-1951. doi: 10.1080/14656566.2019.1657093. Epub 2019 Aug 26.
GroupsApproved; Investigational
Direct ClassificationPhenylpyrimidines
SMILESO=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1
Pathways
PharmGKB
ChEMBLCHEMBL1078178